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Background -Pulmonary neutrophilia characterises both the relatively transient inflammation associated with infant respiratory distress syndrome (IRDS) and the persistent inflammation of chronic lung disease. The possibility that persistently raised markers of inflammation indicate the development of chronic lung disease in low birth weight (<1730 g) preterm (<31 weeks) infants was therefore investigated. Methods -Soluble ICAM-1 (sICAM-1) levels in plasma, and interleukin (IL)-8 and myeloperoxidase (MPO) levels in bronchial lavage fluid (BLF) obtained from 17 infants on days 1, 5, and 14 following birth were measured and correlations with the number of neutrophils in BLF sought. Peripheral neutrophils were isolated on Polymorphoprep and chemotactic responsiveness to IL-8 was assessed using micro Boyden chambers. Results -Sixteen infants developed IRDS and, of these, 10 infants subsequently developed chronic lung disease. Levels of IL-8 in BLF at 14 days of age correlated with the long term requirement for intermittent positive pressure ventilation (IPPV). Interleukin 8 levels in BLF correlated with neutrophil numbers and MPO concentration, suggesting both recruitment and activation in response to this cytokine. Antibody depletion studies showed that approximately 50% of total neutrophil chemotactic activity in BLF was due to No difference in peripheral neutrophil chemotactic responsiveness at any age was observed for infants with IRDS or chronic lung disease. Plasma soluble intercellular adhesion molecule (sICAM-1) was higher at 14 days of age in infants who developed chronic lung disease than in those with resolving IRDS, and correlated with severity of disease, as indicated by duration of IPPV. Conclusions - The results indicate that high levels of plasma sICAM-1 and IL-8 in BLF at day 14 Chronic lung disease of the premature neonate is defined as oxygen dependency for 28 days, together with an abnormal chest radiograph.' This condition sometimes develops as a result of exposure to supplemental oxygen and positive pressure ventilation used to treat the respiratory failure of infant respiratory distress syndrome (IRDS) in premature neonates with surfactant deficiency. ' Neutrophil accumulation in bronchoalveolar lavage fluid characterises the pulmonary inflammation associated with both diseases.45 However, the inflammatory processes in IRDS are self-limiting, and the raised number of neutrophils seen in bronchoalveolar lavage fluid at 2-4 days of age resolve completely within one week of birth.' Conversely, neutrophil counts remain high for at least five weeks in chronic lung disease. Neutrophil migration across endothelial and epithelial cell barriers is dependent on the adhesion receptor ICAM-1, a molecule extensively upregulated in inflammatory disorders. 22 Shedding of cell associated ICAM-1 can be induced by inflammatory cytokines23 and detection of a soluble form of ICAM-1 in the circulation24 has been proposed to be a useful marker of inflammation.25 Thus, raised levels of sICAM-1 have been detected in serum samples from patients with a number of inflammatory disorders26 including bronchial asthma.27 Increased levels of leucocyte-derived L-selectin and endothelial-derived E-selectin in the circulation have similarly been described in systemic inflammation, although organspecific inflammation did not correlate with increased concentrations of these adhesion molecules in the circulation. 26 We therefore investigated bronchial lavage fluid (BLF) levels of IL-8 and serum levels of sICAM-1 as potential markers of the progression of the acute inflammation of IRDS to the chronic phase associated with chronic lung disease. We also compared the IL-8 induced chemotactic responsiveness of peripheral neutrophils from patients with IRDS and those with chronic lung disease.
Methods

PATIENTS
Seventeen infants (26-31 weeks gestation, birth weight 940-1730 g) were consecutively recruited during a five month study which was approved by the local ethical committee. During the study period one infant was not recruited due to the presence of congenital abnormalities. Informed written consent was obtained from both parents at the time of birth, or as soon as possible thereafter. Without parental consent on day 1, five infants were entered into the study on day 5 and three on day 14 . Details of the patients and maternal steroid or infant surfactant therapy are shown in table 1.
STUDY DESIGN
Venous blood (1-2 ml) was obtained on days 1, 5, and 14 and collected into tubes containing EDTA. Bronchial lavage was performed on day 1, 2-4 hours after birth, prior to surfactant administration (Exosurf, an artificial surfactant, 2 x 5 ml/kg), and on days 5 and 14 on those infants who were intubated for intermittent positive pressure ventilation (IPPV) and for whom there were no contraindications. Bronchial lavage was carried out while the infants were supine, with the head turned to the left, and two aliquots (1 ml/kg) of normal saline were introduced via a 5 gauge catheter. Lavage samples were aspirated immediately after each aliquot. In most cases the ventilator circuit was not broken.
The total cell count of BLF was performed on fresh lavage fluid using Kimura stain in a haemocytometer. Differential cell counts were carried out on cytospin slide preparations fixed in methanol and stained with Haema-Gurr differential stain (BDH Ltd, Poole, Dorset, UK). The remaining BLF was centrifuged at 200 g for 10 minutes and the supernatant was frozen in 100 jul aliquots at -80°C.
Chronic lung disease was diagnosed if the infant received IPPV, had persisting oxygen requirement on day 28, and had an abnormal chest radiograph.1 BLF dilution factor The dilution of the epithelial lining fluid by lavage medium was calculated as the ratio of urea concentration in the BLF to urea concentration in the plasma,28 which was measured using an in-house urease-based assay. Concentrations of IL-8 and MPO in BLF and neutrophil numbers were adjusted using this ratio.
IL-8 assay Interleukin 8 was measured by an ELISA which is specific for detection of free IL-8, and does not measure IL-8 in immune complexes. 29 Mouse monoclonal and goat polyclonal antibodies were kindly donated by Dr Ivan Lindley, Sandoz, Vienna, and used as previously described.'°Assays were carried out on neat BLF or plasma diluted 1 in 2 with PBS/0-05% Tween 20.
Neutralisation of IL-8 in BLF Neutralisation of IL-8 in BLF was achieved by incubation of BLF with goat polyclonal anti-IL-8 antibody at 1 gtg/ml for one hour at 4°C.
Bronchial lavage fluid was subsequently centrifuged (one minute at maximum speed in a microfuge) before assay for neutrophil chemotactic activity. In order to demonstrate the specificity of the neutralising antibody, human recombinant (hr) IL-8 and fMLP were treated with the antibody as for BLF, prior to their use in chemotaxis assays. (HBSS with phenol red) was added to the lower chamber in duplicate, and isolated neutrophils (50 p1, 1 x 106/ml) were placed in the upper chamber and incubated for one hour at 37°C. Non-migrating cells on the upper surface of the filter were removed by scraping and washing the filters. Migrated cells on the lower surface were fixed with methanol and stained (HaemaGurr stain) for counting. Five fields of view at 600 x magnification were counted. The neutrophil response was expressed as the average number of cells counted per high power field (hpf) after the value for the buffer control was subtracted. The ED50 was calculated from the dose-response curve as the concentration of IL-8 giving 50% of the maximum response.
DATA ANALYSIS
Correlations were made using Spearman's two tailed rank correlation. Differences between the patient groups were determined using the two tailed Mann-Whitney U test. The effect of maternal antenatal steroid treatment and of Exosurf treatment in the infants on the development ofdisease was analysed using logistic regression analysis by the Medical Statistics Department at Southampton General Hospital.
Results
PATIENTS
The clinical details of the 17 infants recruited to the study are shown in table 1. Sixteen developed RDS, and one had a systemic infection with , haemolytic streptococcus group B. Six of the infants with RDS had an uneventful course, being extubated in air between days 4 and 9 and in whom, therefore, bronchial lavage was not subsequently performed. Ten developed chronic lung disease using the definition of Northway et al.' Logistic regression analysis revealed that neither variation in maternal antenatal steroid treatment nor treatment with Exosurf were significant predictors of chronic lung disease. The antenatal steroids odds ratio=0-17 (95% CI 0-01 to 2 37), p= NS, and the Exosurf odds ratio = 3 0 (95% CI 0-2 to 48), p=NS. (fig 2) .
The neutrophil chemotactic activity of five BLF samples from patients with chronic lung disease was assayed using adult neutrophils and was compared with the response to an optimal concentration of IL-8 ( fig 3) . The neutrophil chemotactic activity of BLF (26.8-52.7 neutrophils/hpf) was greater than that observed with 62-5 ng/ml IL-8 (16 neutrophils/hpf) ( fig  4) . The highest IL-8 concentration measured in the BLF used was 1-6 ng/ml, indicating that neutrophil chemoattractants other than IL-8 were present in BLF. This was tested by treating the samples of BLF with a neutralising IL-8 immune disorders,2526 and our results indicate that plasma sICAM-1 levels may also be diagnostic for the development of chronic lung disease. Higher levels of plasma sICAM-1 in infants with chronic lung disease than in those with IRDS were significantly correlated with the severity of disease, as determined by the subsequent IPPV requirement. A significant increase in plasma sICAM-1 levels was observed on day 5 in infants with IRDS and chronic lung disease. Those with IRDS, in whom inflammation resolved, showed no further increase in this parameter. Only in those with chronic lung disease was a significant increase in plasma sICAM observed at day 14. Thus, sICAM-1 in plasma may reflect endothelial damage at sites of inflammation, particularly in infants with chronic lung disease where persistent neutrophil infiltration of the lungs appears to be mediated by sustained elevated levels of IL-8. The lack of difference in neutrophil chemotactic response to IL-8 indicated that this neutrophil function was not responsible for differences in the course of inflammation in the patient groups. Our experiments did not, however, take into account the possible differential expression of adhesion molecules or other functions in neutrophils from the two groups. Thus, we propose that increased levels of IL-8 in BLF and sICAM-1 in plasma mark the progress ofIRDS to chronic lung disease. Factors which may be important in the regulation of inflammation in IRDS include alpha-i protease inhibitor45 and IL-1 receptor antagonists.44 In view of the importance ofIL-8 in the development of chronic lung disease, we propose that IL-8 autoantibodies in BLF may be important regulators ofthe activity of this cytokine and this is the subject of our current research. This study was supported by a grant from the Wessex Medical Trust, UK.
